Survival rates are estimates based on ... depending on a person’s race, gender, and age. The American Academy of Dermatology states that melanoma develops more often on the legs in females ...

It shows that survival rates have improved in that ... that the risk of skin cancer increases with age and that men are more ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

The team calculated incidence rates and survival outcomes by age, sex, and year of diagnosis. Patricia Pedregal-Pascual, joint first author and clinician specializing in gastroenterology from ...

Melanoma survival rates are poorer than for non-melanoma skin cancer, although when melanoma is diagnosed at an early stage, treatment is easier and more people survive. Skin cancer is the most ...

The burden of low-grade toxicity is clinically significant in patients treated with adjuvant pembrolizumab for stage III melanoma.

immunotherapy is active in malignant melanoma, and clinical trial data suggest that combined chemotherapy and immunotherapy (i.e. biochemotherapy) increases response rates; however, the results of ...

Although the tilsotolimod plus ipilimumab treatment did not meet its co-primary endpoint, these results are a valuable addition to the literature with respect to second-line treatment options in this ...